An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of leucine. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.
An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of leucine. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.
The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|---|---|---|---|---|
INTRAVENOUS | 255 mg in 100 mL | 2021/04/13 | 0338-1091 | ||
INTRAVENOUS | 0.49 g in 100 mL | 2022/08/04 | 0338-1131 | ||
INTRAVENOUS | 300 mg in 100 mL | 2021/04/13 | 0338-1101 | ||
Baxter Healthcare Company | INTRAVENOUS | 300 mg in 100 mL | 2020/09/21 | 0338-1148 | |
Baxter Healthcare Company | INTRAVENOUS | 480 mg in 100 mL | 2020/09/21 | 0338-0214 | |
INTRAVENOUS | 164 mg in 100 mL | 2023/08/02 | 63323-712 | ||
INTRAVENOUS | 360 mg in 100 mL | 2021/04/13 | 0338-0198 | ||
INTRAVENOUS | 1.08 g in 100 mL | 2020/10/07 | 0338-0499 | ||
INTRAVENOUS | 600 mg in 100 mL | 2017/11/16 | 0338-0644 | ||
INTRAVENOUS | 749 mg in 100 mL | 2018/06/01 | 0338-0502 |
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|---|---|---|---|---|
INJECTION | 2.500 g/1000 ml | 2001/09/25 | SIN11682P | ||
INJECTION, EMULSION | 3.284g/1000ml | 2023/03/07 | SIN16734P | ||
SOLUTION, STERILE | 0.85 g/l | 1997/05/27 | SIN09353P | ||
INJECTION, EMULSION | 3.3g/1000ml | 2021/03/24 | SIN16135P | ||
EMULSION | 1.32 g/l | 2004/05/06 | SIN12542P | ||
INJECTION, EMULSION | 5.0g /1000ml | 2013/01/08 | SIN14286P | ||
INJECTION, EMULSION | 5.0g /1000ml | 2013/01/16 | SIN14292P | ||
EMULSION | 2.40 g/l | 2004/05/06 | SIN12539P | ||
INJECTION, EMULSION | 2.256g/1000ml | 2018/04/23 | SIN15468P | ||
EMULSION | 1.26g/L | 2023/10/20 | SIN16888P |
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|
No NMPA products found for this drug
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|---|---|---|---|---|
HK-59165 | Part 1, Schedule 1 & Schedule 3 Poison | POM | 2010/01/28 | ||
HK-36470 | Part 1, Schedule 1 & Schedule 3 Poison | POM | 1992/10/14 | ||
HK-62246 | Part 1, Schedule 1 & Schedule 3 Poison | POM | 2013/10/24 | ||
HK-60999 | b. braun medical (hk) ltd | Part 1, Schedule 1 & Schedule 3 Poison | POM | 2012/01/11 | |
HK-60482 | Part 1, Schedule 1 & Schedule 3 Poison | POM | 2011/05/26 | ||
HK-61206 | otsuka pharmaceutical (h.k.) limited | Part 1, Schedule 1 & Schedule 3 Poison | POM | 2012/04/05 | |
HK-06059 | luen cheong hong ltd | Part 1, Schedule 1 & Schedule 3 Poison | POM | 1979/05/17 | |
HK-61000 | b. braun medical (hk) ltd | Part 1, Schedule 1 & Schedule 3 Poison | POM | 2012/01/11 | |
HK-62100 | wings pharmaceutical ltd | Part 1, Schedule 1 & Schedule 3 Poison | POM | 2013/08/15 | |
HK-62890 | Non-Poison | OTC | 2014/06/06 |
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|---|---|---|---|---|
19609 | Active | 1991/09/30 | isoleucine | ||
117659 | Active | 2007/10/22 | isoleucine | ||
180546 | Active | 2012/01/09 | isoleucine | ||
136599 | Active | 2007/09/04 | isoleucine | ||
141396 | Active | 2007/09/04 | isoleucine | ||
197417 | Active | 2013/08/09 | isoleucine | ||
303755 | Active | 2019/07/01 | isoleucine | ||
308710 | Active | 2018/08/28 | isoleucine | ||
329619 | Active | 2020/08/27 | isoleucine | ||
343446 | Active | 2020/09/14 | isoleucine |